Digest

This podcast features Dr. Brenda Bavan, an REI specialist, discussing infertility diagnosis and treatment. The episode begins by defining infertility according to ASRM guidelines and highlighting its prevalence (affecting 1 in 6-8 couples). The discussion then delves into the initial workup for male infertility, focusing on semen analysis (volume, concentration, motility, morphology) and its interpretation. The limitations of semen analysis and the importance of patient history and genetic screening are also addressed. The female factor workup is systematically reviewed, covering the reproductive tract (vagina, cervix, uterus, tubes, ovaries), age, lifestyle factors, and pre-pregnancy health optimization. Ovarian reserve assessment methods (AMH, FSH, estradiol, AFC) are explained, along with their interpretation. Unexplained infertility, its prevalence, and treatment options (IUI with superovulation and IVF) are discussed, including cost and long-term implications. The podcast concludes by addressing the financial burden of infertility treatments, insurance coverage, and the crucial role of mental health support for patients. Practical advice is offered to primary care physicians on coding and navigating insurance complexities to improve patient access to care.

Outlines

00:00:16

Infertility Workup and Treatment: An Overview

This episode introduces Dr. Bavan and provides an overview of infertility, including its definition, prevalence, and the importance of inclusive language and open communication. It also briefly touches upon the initial workup for both male and female infertility.

00:01:16

Male and Female Infertility Workup

This section details the initial workup for male infertility (semen analysis, patient history, genetic screening) and female infertility (systematic review of the reproductive tract, age, lifestyle factors).

00:03:32

Ovarian Reserve, Unexplained Infertility, and Treatment Options

This section covers ovarian reserve assessment (hormonal testing and AFC), unexplained infertility, and treatment options including IUI and IVF, along with cost and insurance considerations.

00:06:13

Cost, Insurance, and Patient Support in Infertility Care

This section focuses on the financial aspects of infertility treatment, insurance navigation, and the importance of mental health support for patients, offering practical advice for PCPs.

Keywords

Q&A

• What are the key components of a semen analysis, and how are the results interpreted?

  Semen analysis assesses volume, concentration, motility, and morphology of sperm. Normal ranges vary, but low counts in any of these areas may indicate male factor infertility. Referral to a urologist may be necessary for further evaluation.

• How is ovarian reserve assessed, and what are the implications of low ovarian reserve?

  Ovarian reserve is assessed via AMH, FSH, estradiol levels, and AFC. Low levels suggest a diminished egg supply, potentially impacting fertility. However, low AMH doesn't always predict inability to conceive.

• What are the first-line treatment options for unexplained infertility?

  First-line treatment is typically IUI with superovulation. If unsuccessful after several cycles, IVF is often considered. The decision depends on factors like age, cost, and patient preference.

• What are some ways PCPs can support patients navigating infertility?

  PCPs can play a crucial role by normalizing conversations about infertility, performing initial screenings, ordering relevant tests (AMH, FSH, estradiol, semen analysis), and providing counseling and emotional support. They can also help patients understand and navigate insurance coverage complexities.

Show Notes